跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OROXELAM 2,5 MG SOLUCION BUCAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OROXELAM 2,5 MG SOLUCION BUCAL
Approved
STANDARD
OROXELAM 2,5 MG SOLUCION BUCAL
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2021
Approval ID
67e09c4858a3e1db
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
67e09c4858a3e1db
Drug Cima Aemps Name
OROXELAM 2,5 MG SOLUCION BUCAL
Register Number
85757
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2021-02-09
Dosage Form
SOLUCIÓN BUCAL
Dose
2,5 mg
Route Of Administration
Vía bucal (buccal use)
Prescription Type
Uso Hospitalario. Psicótropos
Commercialized
Yes
Company Name
Exeltis Healthcare S.L.
Active Ingredients
MIDAZOLAM
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2021
Approval ID
67e09c4858a3e1db
Type
Standard
Back to CIMA-AEMPS Approvals